Help-sheets on Cytotoxic Drugs for Caregivers

Help-sheets on Cytotoxic Drugs for Caregivers

Type of measure: Organizational

In the realm of cancer treatment, cytotoxic drugs take center stage in oncology departments. However, these potent players pose risks for the dedicated professionals dealing with them. As the landscape of their use constantly shifts—indications, methods, and administration venues evolving—what precautions should be embraced to minimize exposure?

Leaflets and Posters

The INRS have now produced arsenal of documents (leaflets and posters) guiding caregivers how to handle cytotoxic drugs safely. Whether navigating the healthcare battlefield or working from home, the key to a secure performance lies in adopting both collective and individual prevention measures. Safety is the encore to every healthcare or home-setting act.

Note: the documents are currently only available in French

More information
Published January 26, 2024
Relevance
Carcinogen(s) involved:

Sector(s) involved

About this case
Company:
INRS
Country:
France
For more information please contact:
General facts

Facts about cancer-causing agents:

  • The direct costs of carcinogen exposure at work across Europe are estimated at 2.4 billion Euros per year.
  • Every year, about 120.000 persons get cancer from exposure to carcinogens at work
  • Annually more than 100.000 people die because of work-related cancer.
Sign up for our newsletter to become part of our community. Or follow us on LinkedIn and join the conversation!